ABSTRACT: Small interfering RNAs (siRNA) are a potentially powerful new class of pharmaceutical drugs for many diseases, while the delivery of unprotected siRNAs is ineffective due to their susceptibility to degradation by ubiquitous nucleases under physiological conditions. Layered double hydroxide nanoparticles (LDHs) have been found to be efficient carriers of anionic drugs and nucleic acids. Our previous research has shown that LDHs (with the Z-average particle size of approximately 110 nm) can mediate siRNA delivery in mammalian cells, resulting in gene silencing. However, short double-stranded nucleic acids are mostly adsorbed onto the external surface and not well protected by LDHs. In order to enhance the intercalation of siRNA into the LDH interlayer and the efficiency of subsequent siRNA delivery, we prepared smaller LDHs (with the Z-average particle size of approximately 45 nm) with an engineered nonaqueous method. We demonstrate here that dsDNA/siRNA is more effectively intercalated into these small LDH nanoparticles, more dsDNA/siRNA is transfected into HEK 293T cells, and more efficient silencing of the target gene is achieved using smaller LDHs. Thus smaller LDH particles have greater potential as a delivery system for the application of RNA interference.
Introduction
Gene silencing facilitated by RNA interference has proven to be a valuable tool with which to study gene function in the laboratory. RNA interference is mediated by small interfering RNAs (double-stranded RNAs, 21-23 base pairs), which are recognized by the cytoplasmic RNA-inducing silencing complex (RISC) and subsequently unwound. The single-stranded anti-sense RNA then guides RISC to the complementary target mRNA, resulting in its destruction [1, 2] . This targeted degradation of mRNAs has indicated that small interfering RNAs (siRNAs) have great potential as a new class of drugs, particularly in the context of monogenic diseases such as Huntington's disease where silencing of the mutated gene would be expected to reduce or even eliminate the gain-offunction phenotype.
Systemic delivery of naked siRNA to the target tissue is ineffective due to its sensitivity to nuclease degradation and net negative charges which prevents interactions with the plasma membrane [3, 4] . Although the emergence of synthetic gene carriers has broadened the potential applications of siRNA therapeutics to a variety of tissue-specific diseases, most carriers have low biocompatability and/or inadequate delivery kinetics.
Therefore, there is a pressing need to develop biologically compatible, synthetic nanoparticle-based delivery systems to protect the siRNA molecules and promote their cellular uptake. To date, there have been eight clinical trials involving intravenous injection of siRNAs encapsulated in synthetic carriers such as cationic and anionic liposomes, and polymeric carriers [5] [6] [7] . Proof-of-principle has come from the human phase I clinical trials where systemic administration of siRNA encapsulated in cyclodextran-based nanoparticles was found to specifically silence gene expression in 4 solid tumors [5] .
While these studies are encouraging, there remains several challenges in the clinical development of siRNA nanoparticle delivery systems, such as the efficiency of cellular uptake, controlled and sustained release of siRNA from the carrier and enhancement in biocompatibility. Over recent years clay-based nanoparticles, layered double hydroxides (LDHs), have emerged as a siRNA delivery system with the potential to fulfill the above Under these conditions we observed suboptimal loading into the interlayer space with a significant proportion of the short nucleic acids adsorbed onto the LDH surface or partially intercalated into the interlayers [23] . This outcome highlights the need for a new approach to achieving maximum LDH intercalation efficiency for siRNAs under nondenaturing conditions.
One potential solution to the above problem is the use of smaller LDH nanoparticles (S-LDHs). Their larger surface area per unit mass would be expected to increase DNA and siRNA intercalation efficiency. In order to decrease the LDH particle size, we employed an engineered non-aqueous precipitation method [24] . Therefore, the S-LDHs were prepared using a non-aqueous method. Briefly, 10 ml of methanol solution containing Mg(NO 3 ) 2 (6 mmol) and Al(NO 3 ) 3 (2 mmol) was added dropwise to 40 ml methanol solution containing NaOH (16 mmol) under vigorous stirring (10 min) with N 2 bubbling. The mixture was then transferred to a Teflon-lined autoclave, treated at 100 °C for 16 h. After collection by centrifugation and washing twice with deionized water (20 ml), the slurry was resuspended in deionized water (40 ml) with the aid of ultrasonication (30 min), resulting in an LDH suspension containing approximately 8 mg/ml homogeneously dispersed Mg 3 Al-LDH nanoparticles, as characterized by PCS and ICP-AES.
Characterization of LDHs
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The LDH or LDH-DNA suspensions were examined with PCS (Nanosizer Nano ZS, MALVERN Instruments) to determine the particle size distribution and the Zeta potential.
Transmission electron microscope (TEM) images of LDH nanoparticles were obtained on a JEOL JSM-2010 TEM at an acceleration voltage of 200 kV. Prior to TEM microscopy, the diluted suspension was dropped onto a copper grid coated with carbon film.
X-ray diffraction (XRD) patterns of LDH thin films formed on a glass slide were collected on a Rigaku Miniflex X-ray diffractometer with variable slit width at a scanning rate of 2/min with 2 ranging from 5º to 80º using Co K  radiation (=0.17902 nm). For XRD pattern collection, a few drops of LDH or siRNA/dsDNA-LDH suspension were placed on a clean glass slide to form an LDH thin film after drying in a 50 °C oven.
Nucleic acid association with LDH
In some experiments dsDNA was substituted for siRNA of the same sequence to avoid complications arising from RNAase-mediated degradation. We have previously shown 
siRNAs and dsDNAs
Two Silencer® Pre-designed siRNAs (siRNA-DCC#1: 5'-8 GCAAUUUGCUCAUCUCUAATT-3' and siRNA-DCC#2: 5'-CGAUGUAUUACUUUCGAAUTT-3') (Ambion, TX) were derived from the mouse Deleted in Colorectal Carcinoma (DCC) gene [25] .
Complementary strands of dsDNAs (HPLC purified, Geneworks, Australia) were annealed at 37 °C for 1 h. In some instances, both strands of the duplex were covalently coupled to the 6FAM fluorophore at the 5' end before anneal. The sequences of dsDNA-DCC#1 was 5'-GCAATTTGCTCATCTCTAATT -3', and dsDNA-DCC2# 5'-CGATGTATTACTTTCGAATTT -3'.
Cell culture and transfection
Human embryonic kidney cells (HEK 293T) were cultured in L-glutamine containing RPMI-1640 medium (GIBCO, NY) with 10% fetal calf serum, penicillin (10 U/ml) and streptomycin (10 μg/ml, Gibco) in 5% CO 2 at 37 °C. Cells were seeded at a density of Reader (MTX Lab systems, UV, USA) was used to measure the absorbance.
MTT and proliferation assays
Statistics. Each experiment was carried out in duplicate and 3 independent experiments were performed. The data were presented as the mean ± SEM (standard error of the mean). One-way ANOVA and the Dunnett's post-hoc test were used to assess statistical significance. **p<0.01.
Flow cytometry analysis
siRNA/dsDNA-LDH uptake was determined by fluorescence-activated cell sorting Statistics. Data were presented as the mean ± SEM. Two-way ANOVA was used to assess statistical significance. *p<0.05.
Imaging
To ensure that dsDNA-DCC#1-6FAM was not associate with the cell surface, cells
were washed with acidic medium (pH = 3.5) for 30 sec at 4 °C after incubation with 1 µg/ml dsDNA-DCC#1-6FAM-S-LDH to remove any particles bound to the cell surface.
Images of cells were captured on a Zeiss Axio Imager (Carl Zeiss, Germany).
Western blotting
The extent of DCC knockdown was determined by Western blotting 24 h after transfection as previously described [16] . DCC was detected with anti-DCC (G97-446, Pharmingen San Diego, CA). The pixel density of each protein band was determined using Image J software, version 1.35 (National Institutes of Health, MD) and the relative intensity of the DCC protein band was determined by calculating the ratio of the intensity of the DCC band to that of the α-tubulin band (MP Biomaterials, LLC). One-way ANOVA and the Bonferroni post-hoc test were used to assess statistical significance.
*p<0.05.
Results and discussion
Physicochemical features of S-LDHs and L-LDHs
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As previously described, TEM images revealed that synthesis of nanoparticles under aqueous conditions produced L-LDHs with a regular hexagonal shape and the lateral dimension ranging from 100 to 200 nm ( Figure 1A and 1C) [14] [15] [16] . In contrast, the nonaqueous conditions used to prepare S-LDHs (see Experimental) yielded hexagonally shaped particles with lateral dimensions ranging from 20 to 60 nm ( Figure 1B and 1C) .
The Z-average diameter of S-LDHs and L-LDHs, as determined by dynamic light scattering, was 45 and 114 nm, respectively, with a similar polydispersity (Pdi: 0.19 vs. Figure 1C and Table 1 ). The zeta potential for the small pristine nanoparticles (SLDHs) was ~ 45 mV (Table 1) . Similarly, pristine L-LDHs have an average zeta potential of ~43-48 mV [16, 23] , indicating that their surface charge density is equivalent. Figure 2 shows the XRD patterns of as-prepared large and small LDHs. As the measurements were conducted using an in situ-formed thin film (i.e. most LDH plates were laid flatly on the glass substrate), only the basal diffractions, such as (003), (006) and (009), were detected. Both nanoparticles displayed a layered structure, with a dspacing of 0.785 nm for L-LDHs and 0.819 nm for S-LDHs. The former value is very close to that reported for MgAl-Cl-LDH [26] , while the latter is a slightly larger than that for Mg 3 Al-OH-LDH, probably due to intercalation of some methoxide [27] . However, the L-LDH diffraction pattern was stronger and sharper than that produced by S-LDHs, indicating that L-LDHs have better crystallinity. The crystal thickness along the c-axis was estimated (by substituting the full width at the half maximum (FWHM) of peak (003) into the Scherrer's Equation) to be approx. 20 nm for L-LDHs and approx. 5 nm for SLDHs, indicating that S-LDHs comprised four-fold fewer interlayer sheets than L-LDHs. 
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Association of dsDNA with LDHs
XRD analysis was also performed on S-LDHs and L-LDHs after association of dsDNA at 37 o C for 2 h at the mass ratio of dsDNA:LDH = 1:1. Interestingly, in the case of SLDHs, the basal diffractions at (003) and (006) were markedly reduced after dsDNA association, e.g. the stacking of the hydroxide layers was largely distorted, which could be attributed to extensive dsDNA intercalation into the LDH interlayer, at least in the near-edge interlayer region. On the other hand, the XRD patterns of L-LDHs before and after dsDNA loading were very similar, indicating that the dsDNA had less effectively penetrated into the L-LDH interlayer, as reported previously [23] . Therefore, the changes Table 1 shows the Z-average particle size and zeta potential of pristine S-LDHs and dsDNA-S-LDH complexes at the dsDNA:S-LDH mass ratio of 1:1. The dsDNA-S-LDH complexes had an average particle size of 114 nm and a Pdi of 0.55, both larger than those of pristine S-LDHs (45 nm and 0.15), indicating that the complexes were slightly aggregated, with a much broad particle size distribution. This is similar to the case of dsDNA-L-LDHs whose Z-average particle size and Pdi were 149 nm and 0.50, respectively, in comparison with 114 nm and 0.22 of pristine L-LDHs [23] . In addition, both dsDNA-S-LDHs and dsDNA-L-LDHs were negatively charged, with the zeta potential being -28.2 and -36.7 mV, respectively, reflecting that dsDNA was extensively surface adsorbed, and that the surface adsorption of dsDNA was a bit more on L-LDHs.
As the LDH particle size decreases, the exposed specific surface area increases proportionally. Therefore, S-LDHs would be expected to have enhanced surface adsorption of dsDNA/siRNA, which would facilitate their intercalation. Such an effect has previously been reported in the context of anionic dye (300-500 Dalton)-LDH interactions [28] . In their study, Roeffaers and colleagues showed that surface adsorption occurred first and was required for subsequent insertion of the dye into the interlayer.
This implies that in the case of a smaller particle, the same surface association of dsDNA/siRNA would result in a higher degree of intercalation than in a larger particle given the interactions between the brucite-like layers and the interlayer anions are similar.
As the XRD analysis of dsDNA-S-LDHs showed that the basal diffractions at (003) and (006) were markedly reduced compared to those generated from pristine S-LDHs, the stacking of the hydroxide layers could be severely disrupted as a result of a higher degree of dsDNA intercalation. In contrast, there was little difference in the XRD patterns of L- 15 LDHs before and after dsDNA loading, implying intercalation of dsDNA/siRNA into the interlayer was minimal [23] . As already discussed in our previous paper [23] , the dsDNA loading on L-LDHs was 0.2-0.3 µg (dsDNA)/µg (L-LDHs) at the mass ratio of 1:1, where the dsDNA was largely associated with the LDH particle surface. For S-LDHs (45 nm), we would estimate that the loading of dsDNA was 0.4-0.5 µg (dsDNA)/µg (SLDHs) at the same mass ratio under the same conditions. Consequently, the intercalation of dsDNA into the S-LDH interlayers would be double that predicted for the L-LDH interlayers if we assume that intercalation is proportional to the surface-adsorbed amount.
Therefore, we conclude that the reduction in LDH size greatly facilitates the loading of short double-stranded nucleic acids, thereby allowing less stringent anion exchange conditions to be employed for siRNA adsorption/intercalation. 
S-LDHs have low cytotoxicity
Small LDH nanoparticles have been reported to be more cytotoxic due to their increased surface area per unit mass [20, 29] . Therefore, we determined the cytotoxicity 16 of S-LDHs in HEK 293T cells exposed to pristine S-LDHs (0-200 μg/ml) for 48 h after which their viability was assessed using the MTT assay ( Figure 3A) . We observed no significant loss of cell viability across this concentration range. This is consistent with our previous observations that at an L-LDH concentration of up to 500 μg/ml cell viability was found to be greater than 80-90% in various cell lines [12, 15, 30, 31] . As a second measure of cell viability, we investigated the effect of S-LDHs on the ability of HEK 293T cells to proliferate after 48 h exposure ( Figure 3B ). At 12.5 μg/ml of S-LDHs the proliferation rate was indistinguishable from that of control cultures, whereas the proliferation decreased to 81% at 25 μg/ml. At high concentrations (100-200 μg/ml) only 62% cells were able to proliferate. Previously, we reported that the proliferation rate was 70-80 % at 25 μg/ml L-LDHs for HEK 293T cells [15, 31] . Together these data show that, like L-LDHs (110 nm), S-LDHs (45 nm) have negligible cytotoxicity at low, biologically relevant concentrations (i.e. up to 25 μg/ml). Therefore, the concentrations of siRNA/dsDNA and LDH at no more than 10 μg/ml (1:1 mass ratio) used in subsequent experiments ensure the minimal disturbance of cell viability and proliferation. 4B and Table 2 ). Moreover, the extent of internalization for individual cells was markedly greater for the S-LDH complexes at this dsDNA concentration. The median fluorescence intensity (FI) for the population exposed to the S-LDH complexes was 2.9 FI units, while only 1.6 FI units for cells exposed to the L-LDH complexes (Table 2) . Therefore, S-LDH-mediated dsDNA internalization was nearly 2-fold more efficient than L-LDH-mediated internalization. Table 2 This difference in S-LDH and L-LDH uptake efficiency was also observed at a dsDNA concentration of 1 μg/ml ( Figure 4B and Table 2 ). In this case 4% of cells were 6FAM-positive after exposure to the S-LDH complexes and the median FI for the population was 1.9, whereas only 0.5% of cells internalizing the L-LDH complexes and the median FI was 1.7. As previously observed [16] , very few cells were found to be 6FAM-positive when using a dsDNA concentration of 0.1 μg/ml with either S-LDHs or L-LDHs (Table   19 2). Taken together, the above results clearly demonstrate that the smaller LDH nanoparticles are able to more effectively transport short double-stranded nucleic acids into HEK 293T cells. The higher efficiency can be largely attributed to the higher loading of dsDNA on S-LDHs. The second reason could be the smaller particle size as Oh et al has also reported that small LDHs were a more effective transport vehicle for MNNG/HOS cells [8] .
Gene silencing using LDH-mediated delivery of siRNA
Our previous study demonstrated that L-LDH-mediated siRNA delivery results in gene-specific silencing in HEK 293T cells and cultured neurons [15, 16] . To compare the effectiveness of RNA interference after delivery using S-LDHs and L-LDHs, we targeted the neuronal gene DCC [25] , and used the mass ratios of 1:1 to prepare the siRNA-LDH complexes. HEK 293T cells were first transfected with the DCC expression plasmid. Six hours later the transfection medium was replaced with fresh culture medium containing control siRNA-or DCC siRNA-LDH complexes (final concentration of siRNA = 250 nM, i.e. 3.25 µg/ml) for a further 24 h. Cell lysates were then subjected to Western blotting using an antibody specific for the DCC protein and an anti-α-tubulin antibody as the loading control ( Figure 5A ). DCC protein levels were quantified relative to α-tubulin levels using densitometry. The extent of knockdown was then calculated as the percentage of DCC protein relative to that in untreated cells. As shown in Figure 5B , substantial knockdown of DCC expression was seen after incubation with siRNA-DCC-S-LDH (43% knockdown), whereas approx. 20% knockdown was achieved using LLDHs at this mass ratio. Significantly higher S-LDH-mediated knockdown of DCC can 20 be attributed to the following factors: (1) more siRNA was associated with S-LDHs due to greater surface adsorption and subsequent intercalation; (2) S-LDHs were a more efficient vehicle for dsDNA/siRNA cellular delivery ( Figure 4B ) [8] ; and (3) dsDNA-S-LDH complexes were less negatively charged leading to smaller aggregates (-28.2 mV and 114 nm, Table 1 ) compared to dsDNA-S-LDH complexes (-36.7 mV and 149 nm, Table 1 ). Therefore, we conclude that S-LDHs are a better vehicle for siRNAs delivery. 
Conclusions
In this study we developed a non-denaturing anion exchange protocol which permitted high capacity intercalation of functional siRNAs into small LDH nanoparticles (S-LDHs, 21 45 nm), whereas the extent of intercalation into L-LDH (114 nm) interlayers under the same conditions was much reduced. Our investigation of the physicochemical properties of S-LDHs suggests that the enhanced S-LDH loading capacity was due to an increase in both the high specific surface area. Although both S-LDHs and L-LDHs transported short double-stranded nucleic acids into HEK 293T cells effectively, S-LDH-mediated internalization was considerably more efficient at the mass ratio of 1:1. Importantly, S-LDH-mediated siRNA delivery resulted in more extensive targeted gene silencing compared to L-LDH-mediated. In addition, reduction in LDH particles size did not affect cell viability at a concentration up to 200 μg/ml, and proliferative ability was not disturbed at biologically relevant concentrations (25 μg/ml or less). Therefore, smaller LDH particles will have greater potential as a drug delivery system for the application of RNA interference.
